Skip to main content

Elbit Systems Wins $277 Million International Contract for 30mm Turrets and Munitions

Tipranks - Thu Feb 19, 5:41AM CST

President's Day Sale - 70% Off

Elbit Systems ( (IL:ESLT) ) has provided an announcement.

On February 18, 2026, Elbit Systems announced it had secured contracts worth a combined $277 million from an unnamed international customer to supply 30mm UT30 MK2 turrets and related munitions over three years. The modular, low‑profile turrets can be configured as manned or unmanned and integrate a 30mm main gun, coaxial 7.62mm weapon and anti‑tank guided missiles, enhancing the firepower and survivability of armored personnel carriers.

The award underscores continued demand for Elbit’s advanced land systems and strengthens its already substantial backlog, signaling further revenue visibility and reinforcing its competitive positioning in the global defense market. Management highlighted that the repeat business reflects customer confidence in the company’s technology and its ability to deliver operational capabilities to armed forces worldwide.

The most recent analyst rating on (IL:ESLT) stock is a Buy with a ILs256849.00 price target. To see the full list of analyst forecasts on Elbit Systems stock, see the IL:ESLT Stock Forecast page.

More about Elbit Systems

Elbit Systems Ltd. is a leading global defense technology company that develops, manufactures, integrates and sustains next‑generation military solutions across multiple domains. Headquartered in Haifa, Israel, it leverages the local technology ecosystem and employs around 20,000 people in dozens of countries, reporting $1.922 billion in revenue for the quarter ended September 30, 2025 and an order backlog of $25.2 billion. The company focuses on advanced land systems, munitions and other defense technologies for armed forces worldwide.

Average Trading Volume: 77,831

Technical Sentiment Signal: Buy

Current Market Cap: ILs96.79B

Find detailed analytics on ESLT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.